Algernon Pharmaceuticals Inc.

AGN:CSE; AGNPF:OTCQB; AGN0:XFRA

Streetwise - Algernon Pharmaceuticals Inc. Ownership Overview*

Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGN0:XFRA)

*Share Structure as of 4/13/2023

Company News 

9/6/2023 – Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH